[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

Global Statistics Representing Antitumor Antibiotic Market Scenario

Antitumor antibiotic drugs are used in chemotherapy to treatment different types of cancers such as leukemia, bladder cancer, and others. In every three minutes a person is diagnosed with leukemia in the U.S and it is also one of the most common cancers among children. Around 437,033 new cases of leukemia were diagnosed in 2018 worldwide, the American Institute for Cancer research. Today, the market is packed with a wide range of chemotherapy drugs, let it be single drug or combination of drugs.  Anthracyclines is one of the leading types of antitumor antibiotic drugs and has been effectively used for treating leukemia, ovarian, breast, stomach, and other cancer therapies. Anthracyclines are also used in breast cancer treatment. Over 13 million electronic medical records exist in the U.S. for cancer patients.

Global antitumor antibiotic market accounted for around USD 3,000 million in 2017 and is expected to grow at a CAGR of 5.3% during the forecast period, 2019–2026.

Intended Audience

  • Antitumor Antibiotic Manufacturers
  • API Manufacturers
  • Potential Investors
  • Biotechnological & Pharmaceutical Companies
  • Research and Development Institutes

 Segmental Insights

Global antitumor antibiotic market is segmented by drug type and distribution channel.

By drug type, the market is segmented into anthracyclines, chromomycins, and miscellaneous. Anthracyclines is projected to witness huge demand in the coming years on account of growing prevalence of leukemia and bladder cancers. Moreover, its use in combination therapy has shown promising results during treatment. Anthracycline in chemo regime has shown better results than without anthracycline chemotherapy. As per study conducted on 4,130 women suffering from breast cancer for anthracyclines therapy showed that women lived longer without reassurance of cancer.

By distribution channel, the antitumor antibiotic market is segmented into hospitals, retail pharmacies, and online. Hospitals are holding the major grip on market, which be a result of easy availability of drugs and large patient population visiting hospitals.

Regional Insights

Geographically, the global antitumor antibiotic market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA).

From the past few years, the overall prevalence of cancer has grown exponentially across the Americas. Currently, the region is burdened with high demand for effective drugs to treat this disease. In a study, it has been found that the prevalence of cancer is higher among older patients in the U.S. For instance, around 87% of cancers are diagnosed in the people above 50 years. This has again increased the economic burden on the country. In 2015, the direct medical cost for cancer treatment was accounted for around USD 80.2 billion in the U.S.  So far, numerous drugs have been introduced to the market and many more are in pipeline. For instance, 14 new active substances for cancer therapeutics were launched in 2017 and 11 of them were categorized under breakthrough therapy by the Food and Drugs Administration.

Asia Pacific is expected to witness significant growth during the forecast period. The region has large cancer population. Prevalence of breast cancer in Asia is much higher than western countries, which is mainly attributed to rapid lifestyle changes, especially fertility pattern. In addition, lack of awareness is another prominent concern in the region. Apart from this, some well-educated countries such as South Korea and Japan have stigmatized the breast cancer issue leading to high untreated population. To tackle this crucial situation, policymakers need to follow a comprehensive plan, which include screening, affordable drugs, and better healthcare policies. Governments in the region are focused on providing sustainable treatment. For instance, India has 27 region cancer centers, and the government provides up to 50,000 financial support to poor patients. China has reduced import tariff on major cancer drugs, including 39 patented drugs to reduce the prices of these drugs. Moreover, Japan has simplified the average development times and the regulatory approval process for new molecules to encourage better treatment alternatives.

Key Players

Some of the key players in the global antitumor antibiotic market are Astellas Pharma Inc. (Japan), Johnson & Johnson Services, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG ​ (Switzerland), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), AG Scientific (U.S.), and Amgen Inc. (U.S.).      

 Antitumor Antibiotic Market Segmentation

By Drug Type

  • Anthracyclines
    • Daunorubicin
    • Doxorubicin
    • Idarubicin
    • Epirubicin
  • Chromomycins
    • Dactinomycin
    • Plicamycin
  • Miscellaneous
    • Mitomycin
    • Bleomycin

By Distribution Channel

  • Hospitals
  • Retail Pharmacies
  • Online

Regions Covered

  • America
    • North America
      • U.S.
      • Canada
      • Mexico
    • South America
  • Europe
    • Western Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Western Europe
    • Eastern Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • The Middle East & Africa 
    • The Middle East
      • Saudi Arabia
      • UAE
      • South Africa
      • Rest of the Middle East

Why buy this report right now?

Our report covers heart pump device market insights, focusing on recent development in the market in different region and development strategies of the companies. Moreover, the following sections are specifically covered in the report.
• Definitive Market Data
• Hematology diagnostic market Analysis
• Competitive Analysis
• Recent Opportunities in the Market
• 6-7 year performance forecasts: major segments covering top product type, end-user application, and geographies
• Market Share Analysis
• Potential Venture Avenues



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports